Quantifying the effect of eccentric ruthenium plaque placement on tumor volume dose.

brachytherapy eccentric melanoma ruthenium

Journal

Journal of contemporary brachytherapy
ISSN: 1689-832X
Titre abrégé: J Contemp Brachytherapy
Pays: Poland
ID NLM: 101506276

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 30 05 2023
accepted: 30 10 2023
medline: 17 1 2024
pubmed: 17 1 2024
entrez: 17 1 2024
Statut: ppublish

Résumé

Ruthenium-106 brachytherapy is a common treatment for small to medium-sized uveal melanomas. In certain clinical contexts, plaques may be placed eccentrically to tumor center. The effect of plaque decentration, a common radiation dose measurement in radiotherapy: D Using a Plaque Simulator™ (Eye Physics) plaque modelling software, treatment time required to deliver 100 Gy D D Eccentric plaque placement reduces the radiation dose delivered to choroidal tumors. Both tumor (thickness, diameter) and plaque (size, location) characteristics are important D

Identifiants

pubmed: 38230400
doi: 10.5114/jcb.2023.133614
pii: 52015
pmc: PMC10789163
doi:

Types de publication

Journal Article

Langues

eng

Pagination

442-447

Informations de copyright

Copyright © 2023 Termedia.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Auteurs

Jeremy P M Flanagan (JPM)

Ophthalmology, Department of Surgery, University of Melbourne, Melbourne (Victoria), Australia.
Ocular Oncology Research Unit, Centre for Eye Research Australia, Melbourne (Victoria), Australia.

William H F Udovenya (WHF)

Ophthalmology, Department of Surgery, University of Melbourne, Melbourne (Victoria), Australia.

Melvin A Astrahan (MA)

Department of Radiation Oncology, Keck School of Medicine, University of Southern California, Los Angeles (California), USA.

Daniel McKay (D)

Ocular Oncology Research Unit, Centre for Eye Research Australia, Melbourne (Victoria), Australia.
Department of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia.

Claire Phillips (C)

Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne (Victoria), Australia.

John D McKenzie (JD)

Department of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia.

Roderick O'Day (R)

Ocular Oncology Research Unit, Centre for Eye Research Australia, Melbourne (Victoria), Australia.
Department of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia.

Lotte S Fog (LS)

Department of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia.
Alfred Health Radiation Oncology, The Alfred, Melbourne (Victoria), Australia.

Classifications MeSH